3 High Growth Tech Stocks Leading The US Market

Simply Wall St.11-07

The United States market has shown robust performance, rising 2.3% over the last week and 35% over the past year, with earnings forecasted to grow by 15% annually. In this thriving environment, a good...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2481465186?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","is_english":true,"pubTime":"2024-11-07 22:10","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2481465186","market":"us","top_or_hot":-1,"title":"3 High Growth Tech Stocks Leading The US Market","media":"Simply Wall St.","content":"<div>\n<p>The United States market has shown robust performance, rising 2.3% over the last week and 35% over the past year, with earnings forecasted to grow by 15% annually. In this thriving environment, a good...</p>\n\n<a href=\"https://finance.yahoo.com/news/3-high-growth-tech-stocks-141048086.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 High Growth Tech Stocks Leading The US Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 High Growth Tech Stocks Leading The US Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-07 22:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/3-high-growth-tech-stocks-141048086.html><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The United States market has shown robust performance, rising 2.3% over the last week and 35% over the past year, with earnings forecasted to grow by 15% annually. In this thriving environment, a good...</p>\n\n<a href=\"https://finance.yahoo.com/news/3-high-growth-tech-stocks-141048086.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MDGL","symbol_name":"Madrigal Pharmaceuticals, Inc.","start_time":0,"source_url":"https://finance.yahoo.com/news/3-high-growth-tech-stocks-141048086.html","article_id":"2481465186","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2481465186","pubTimestamp":1730988648,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"The United States market has shown robust performance, rising 2.3% over the last week and 35% over the past year, with earnings forecasted to grow by 15% annually. In this thriving environment, a good stock often combines strong growth potential with innovative technology solutions that align well with current market trends and future growth expectations.Top 10 High Growth Tech Companies In The United States. Click here to discover the nuances of ADMA Biologics with our detailed analytical health report.Understand ADMA Biologics' track record by examining our Past report.Operations: Madrigal Pharmaceuticals focuses on developing treatments for non-alcoholic steatohepatitis  in the U.S. As a clinical-stage company, it does not currently generate revenue from product sales.","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"MDGL":"Madrigal Pharmaceuticals, Inc.","LU0289961442.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"AX\" (SGD) ACC","BK4139":"生物科技","LU0472753341.HKD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (HKD) ACC","LU0353189680.USD":"富国美国全盘成长基金Cl A Acc","LU0057025933.USD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"AX\" (USD) ACC","BK4023":"应用软件","LU0511384066.AUD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (AUDHDG) ACC","BK4585":"ETF&股票定投概念","ADMA":"ADMA Biologics Inc","FICO":"Fair Isaac Corp","LU2087625088.SGD":"ALLSPRING  US ALL CAP GROWTH \"A\" (SGDHDG) ACC","LU0289739343.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (SGD) ACC","LU0069063385.USD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (USD) ACC","IE00B64QTZ34.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) ACC","BK4588":"碎股","LU0353189763.USD":"ALLSPRING  US ALL CAP GROWTH FUND \"I\" (USD) ACC","IE00BLDYK493.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) INC"},"translate_title":"引领美国市场的3只高增长科技股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FICO":1,"MDGL":0.9,"ADMA":0.9},"content_text":"The United States market has shown robust performance, rising 2.3% over the last week and 35% over the past year, with earnings forecasted to grow by 15% annually. In this thriving environment, a good stock often combines strong growth potential with innovative technology solutions that align well with current market trends and future growth expectations.\nTop 10 High Growth Tech Companies In The United States\n\n\n\nName\nRevenue Growth\nEarnings Growth\nGrowth Rating\n\n\nSarepta Therapeutics\n23.80%\n44.01%\n★★★★★★\n\n\nInvivyd\n47.87%\n67.72%\n★★★★★★\n\n\nAmicus Therapeutics\n20.10%\n62.00%\n★★★★★★\n\n\nTG Therapeutics\n34.66%\n56.48%\n★★★★★★\n\n\nAlkami Technology\n21.89%\n98.60%\n★★★★★★\n\n\nAlnylam Pharmaceuticals\n22.41%\n70.53%\n★★★★★★\n\n\nBlueprint Medicines\n25.26%\n68.92%\n★★★★★★\n\n\nTravere Therapeutics\n31.20%\n72.26%\n★★★★★★\n\n\nSeagen\n22.57%\n71.80%\n★★★★★★\n\n\nImmunoGen\n26.00%\n45.85%\n★★★★★★\n\n\n\nClick here to see the full list of 236 stocks from our US High Growth Tech and AI Stocks screener.\nLet's explore several standout options from the results in the screener.\nADMA Biologics\nSimply Wall St Growth Rating: ★★★★☆☆\nOverview: ADMA Biologics, Inc. is a biopharmaceutical company focused on developing, manufacturing, and marketing specialty plasma-derived biologics for treating immune deficiencies and infectious diseases globally, with a market cap of $4.39 billion.\nOperations: The company generates revenue primarily through its ADMA Biomanufacturing segment, contributing $326.70 million, and its Plasma Collection Centers, adding $3.41 million.\nADMA Biologics, recently added to the S&P 600 and 1000 indices, underscores its growing prominence in biotech. With a robust Q3 performance, ADMA posted revenues of $107.19 million, marking a substantial increase from the previous year's $60.12 million. This financial uptick is mirrored in their net income surge to $32.06 million from a prior loss, highlighting operational efficiencies and market penetration. Notably, R&D expenditures remain pivotal, aligning with their strategic focus on innovation—a critical driver in biotech's fast-evolving landscape. Their recent auditor change to KPMG could enhance fiscal scrutiny and investor confidence, potentially influencing future financial health and stock stability.\n\nClick here to discover the nuances of ADMA Biologics with our detailed analytical health report.\nUnderstand ADMA Biologics' track record by examining our Past report.\n\n\n\n\n  NasdaqGM:ADMA Earnings and Revenue Growth as at Nov 2024\n \n\nMadrigal Pharmaceuticals\nSimply Wall St Growth Rating: ★★★★★☆\nOverview: Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing therapeutics for treating non-alcoholic steatohepatitis (NASH) in the United States, with a market cap of $7.36 billion.\nOperations: Madrigal Pharmaceuticals focuses on developing treatments for non-alcoholic steatohepatitis (NASH) in the U.S. As a clinical-stage company, it does not currently generate revenue from product sales.\nDespite a challenging financial landscape, Madrigal Pharmaceuticals has demonstrated a notable commitment to growth and innovation, particularly in its pursuit of treatments for NASH cirrhosis. The company's R&D expenses are substantial, reflecting its strategic focus on developing cutting-edge therapeutic solutions. Recent trials like the MAESTRO-NASH OUTCOMES indicate progress and potential within biotech's specialized sectors. Moreover, with revenue forecasts projecting an impressive annual increase of 54.2%, Madrigal is poised for significant market expansion once profitability is achieved, expected within the next three years with earnings growth forecasted at 73.2%. This trajectory underscores its potential impact on both healthcare outcomes and sector dynamics despite current unprofitability and high volatility in share price.\n\nClick to explore a detailed breakdown of our findings in Madrigal Pharmaceuticals' health report.\nGain insights into Madrigal Pharmaceuticals' past trends and performance with our Past report.\n\n\n\n\n  NasdaqGS:MDGL Earnings and Revenue Growth as at Nov 2024\n \n\nFair Isaac\nSimply Wall St Growth Rating: ★★★★☆☆\nOverview: Fair Isaac Corporation specializes in developing analytic, software, and digital decisioning technologies to help businesses improve decision-making processes globally, with a market cap of approximately $49.28 billion.\nOperations: Fair Isaac Corporation generates revenue primarily from two segments: Scores, contributing $866 million, and Software, bringing in $787.45 million. The company focuses on providing technologies and services that automate and enhance decision-making processes across various regions worldwide.\nFair Isaac, known for its analytical tools and credit scoring models, continues to innovate in financial technology. Recently reporting a robust annual revenue increase to $1.72 billion, the company's commitment to R&D is evident with a significant portion of its budget dedicated here, aligning with an 18.6% forecast in earnings growth per year. This strategic focus is further exemplified by their latest product launch, the FICO® Score Mortgage Simulator, which enhances loan accessibility and decision-making for mortgage professionals through advanced simulations of credit score scenarios. Additionally, Fair Isaac's collaboration with Tata Consultancy Services aims to integrate cutting-edge AI and optimization solutions across various industries globally, potentially reshaping operational efficiencies and decision-making processes in sectors prone to rapid technological advancements.\n\nDive into the specifics of Fair Isaac here with our thorough health report.\nGain insights into Fair Isaac's historical performance by reviewing our past performance report.\n\n\n\n\n  NYSE:FICO Earnings and Revenue Growth as at Nov 2024\n \n\nTaking Advantage\n\nEmbark on your investment journey to our 236 US High Growth Tech and AI Stocks selection here.\nHave a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.\nTake control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.\n\nWant To Explore Some Alternatives?\n\nExplore high-performing small cap companies that haven't yet garnered significant analyst attention.\nFuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.\nFind companies with promising cash flow potential yet trading below their fair value.\n\n This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.\nCompanies discussed in this article include NasdaqGM:ADMA NasdaqGS:MDGL and NYSE:FICO.\nHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2481465186"}